CADILA HEALTHCARE LTD.

NSE : CADILAHCBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE462.50-5.9 (-1.26 %)
PREV CLOSE ( ) 468.40
OPEN PRICE ( ) 472.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 462.50 (5)
VOLUME 191745
TODAY'S LOW / HIGH ( )460.60 474.00
52 WK LOW / HIGH ( )329.95 558
NSE462.65-5.85 (-1.25 %)
PREV CLOSE( ) 468.50
OPEN PRICE ( ) 471.90
BID PRICE (QTY) 462.65 (2)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 630195
TODAY'S LOW / HIGH( ) 460.10 474.65
52 WK LOW / HIGH ( )328.8 560
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 15-05 1995
Management Info
Pankaj R Patel - Chairman Sharvil P Patel - Managing Director
Registered Office

Address Formulation Units,Zydus Tower,Satellite Cross Roads,
Ahmedabad,
Gujarat-380015

Phone 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20

Email investor.grievance@zyduscadila.com

Website www.zyduscadila.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX
NEWS
23Aug Zydus Cadila gets final approval from
Zydus Cadila has received the final approval from the United States Food..
22Aug Zydus Cadila gets final approval from
Zydus Cadila has received the final approval from the United States Food..
22Aug Zydus Cadila gets final approval from
Zydus Cadila has received the final approval from the United States Food..
22Aug Cadila Healthcare informs about press
Cadila Healthcare has informed about press release titled ‘Zydus receive..
22Aug Cadila Healthcare informs about compan
Cadila Healthcare has informed about disclosure under Regulation 7[2] of..
Financials
Rs. in Millions
QTR Jun 17 ANNUAL 17
Net Profit9146619
Gross Profit 1721 6422
Operating Profit 25049042
Net Sales 1055432745
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Pfizer (BSE)
 1808.95 (3.16%)
M.Cap (Rs. in Cr)8275.54
Piramal Enterprises (BSE)
 2625.45 (1.81%)
M.Cap (Rs. in Cr)45305.58
Alkem Laboratories (BSE)
 1798.25 (2.66%)
M.Cap (Rs. in Cr)21500.78
Dr. Reddys Lab (BSE)
 2029.50 (2.25%)
M.Cap (Rs. in Cr)33660.66
Ajanta Pharma (BSE)
 1191.25 (3.52%)
M.Cap (Rs. in Cr)10483.71
Shareholding Pattern
PROMOTERS 74.79%
NON-INSTITUTION 7.79%
MUTUAL FUNDS/UTI 3.68%
FI/BANKS/INSURANCE 3.6%
GOVERNMENT 0.1%
FII 0%
ATTENTION INVESTORSKYC
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.